Published 2025-01-01
“…Trakanta Wannapanich,1,2 Vilavun Puangsricharern,1,3 Vannarut Satitpitakul,1,3 Thanachaporn Kittipibul,1,3 Kanya Suphapeetiporn4– 6 1Center of Excellence for Cornea and Stem Cell Transplantation, Department of Ophthalmology,
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 2Excellence Center for Cornea and Stem Cell Transplantation, Department of Ophthalmology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; 3Department of Ophthalmology,
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 4Department of Pediatrics,
Faculty of Medicine, Chulalongkorn University Bangkok, Bangkok, Thailand; 5Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand; 6Center of Excellence for Medical Genomics, Department of Pediatrics,
Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCorrespondence: Vilavun Puangsricharern, Department of Ophthalmology,
Faculty of Medicine, Chulalongkorn University, 1873, Rama 4 Road, Pathumwan, Bangkok, 10330, Thailand, Email vilavun@hotmail.com Kanya Suphapeetiporn, Department of Pediatrics,
Faculty of Medicine, Chulalongkorn University, 1873, Rama 4 Road, Pathumwan, Bangkok, 10330, Thailand, Email kanya.su@chula.ac.thPurpose: To describe the demographic profile, clinical characteristics, and treatment trends of Fuchs endothelial corneal dystrophy (FECD) in Thai patients, reflecting the evolving landscape of corneal transplantation in this region.Patients and Methods: This retrospective cohort study included 900 patients (1,743 eyes) diagnosed with FECD at a tertiary referral center in Thailand between January 2017 and June 2023. …”
Get full text
Article